Axay Tomar: Precision Transfusion and Optimizing Blood Component Therapy in Hematology
Axay Tomar, Associate Professor at Indian Army, shared a post on LinkedIn:
“Blood component therapy is a cornerstone in managing hematological disorders, offering targeted transfusion strategies to optimize patient outcomes.
This chapter explores the role of various blood components, including packed red blood cells (PRBCs), platelets, fresh frozen plasma (FFP), and cryoprecipitate, in treating anemia, thrombocytopenia, and coagulopathies.
PRBC transfusions focus on restrictive strategies to balance oxygen delivery while minimizing risks such as iron overload and transfusion reactions.
Platelet transfusions are essential in thrombocytopenia management, with strict guidelines to prevent transfusion refractoriness and alloimmunization.
FFP plays a critical role in coagulation factor replacement, particularly in disseminated intravascular coagulation (DIC) and massive transfusion protocols.
The chapter also highlights the complex transfusion needs of hematopoietic stem cell transplantation (HSCT) patients, emphasizing the importance of leukoreduction, irradiation, and ABO compatibility.
Special considerations for autoimmune hemolytic anemia (AIHA) and fetal anemia due to Rh isoimmunization are discussed, underlining the challenges in immunohematology.
Advances in blood component modifications, including leukoreduction, pathogen reduction, and extended antigen matching, continue to enhance transfusion safety and efficacy.
The chapter stresses the importance of evidence-based transfusion thresholds, personalized treatment approaches, and emerging innovations to ensure optimal patient care.”
Stay updated with Hemostasis Today.
-
Aug 19, 2026, 01:43Elvira Grandone: Cancer and Thrombosis in Women – Where Do We Stand?
-
Aug 19, 2026, 01:37Ifeanyichukwu Ifechidere: Coagulation Knowledge – A Core Skill in Internal Medicine
-
Aug 19, 2026, 01:34Tommy Alfaro Moya: Celebrating a New Chapter Contribution in Clinical Hematology and Hemato-Oncology
-
Aug 19, 2026, 01:21Navigating the Unpredictability of Factor VII Deficiency – EHC
-
Aug 18, 2026, 19:49Make the Most of Your Summer and Catch Up on Gene Therapy – EAHAD
-
Aug 18, 2026, 19:46Lesley Van Wyk: ANA Testing – From Screening to Interpretation
-
Aug 18, 2026, 19:45Factor IV – The ‘Coagulation Factor’ That Isn’t a Protein – ICHCC
-
Aug 18, 2026, 19:42Melanie Jay: What Should Behavioral Support Look Like Alongside Obesity Medications?
-
Aug 18, 2026, 19:40Subodh Verma: Tirzepatide Improves Multiple Cardiovascular Risk Pathways